Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Dose-response relationship in cisplatin-treated breast cancer xenografts monitored with dynamic contrast-enhanced ultrasound

Figure 2

Changes of tumor perfusion after treatment with different dose cisplatin. (A) Representative contrast-enhanced ultrasound images of tumors (arrows) from Group A, Group B and Group C on day 7. (B) Changes of tumor perfusion parameters at the different time points studied. On days 3, tumor perfusion significantly decreased in group C when compared with group A (* = P < 0.05). On day 7, tumor perfusion significantly decreased in group B and group C when compared with group A (* = P < 0.05), and further decreased in group C when compared with group B (* = P < 0.05). Group A, control tumors; Group B, tumors treated with 1 mg/kg cisplatin; Group C, tumors treated with 3 mg/kg cisplatin.

Back to article page